COVID-19 neutralizing antibodies predict disease severity and survival
●Severe COVID-19 associates with higher antibody production and neutralization titers
●
Neutralization potency of anti-RBD antibodies predicts disease severity and survival
●
Immunomodulatory COVID-19-directed therapies modulate antibody responses
●
COVID-19 sera neutralize D614 and G614 variants, but not pre-emergent WIV1-CoV